Literature DB >> 21235433

Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.

Sonya E L Craig1, Susann M Brady-Kalnay.   

Abstract

Receptor protein tyrosine phosphatase (RPTPs) are involved in many cellular processes, including the regulation of adhesion, migration and cellular signaling. Many RPTPs are putative tumor suppressors because of the transcriptional and translational changes observed in their expression during tumorigenesis. Recently, RPTPs were shown to be post-translationally regulated during tumorigenesis by proteolysis in a manner similar to proteolysis of the Notch receptor. There is accumulating evidence that proteolysis of RPTPs influence their cellular function and that RPTP fragments may function as oncogenes. By exploiting what is known about RPTP ligand binding domains and crystal structures of ligand-RPTP interfaces, we describe novel molecular diagnostics that have been or can be developed to identify tumor margins and target tumor tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235433      PMCID: PMC3337336          DOI: 10.2174/187152011794941244

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  77 in total

1.  Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.

Authors:  David A Solomon; Jung-Sik Kim; Julia C Cronin; Zita Sibenaller; Timothy Ryken; Steven A Rosenberg; Habtom Ressom; Walter Jean; Darell Bigner; Hai Yan; Yardena Samuels; Todd Waldman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

2.  Risk of ovarian cancer and inherited variants in relapse-associated genes.

Authors:  Abraham Peedicayil; Robert A Vierkant; Lynn C Hartmann; Brooke L Fridley; Zachary S Fredericksen; Kristin L White; Elaine A Elliott; Catherine M Phelan; Ya-Yu Tsai; Andrew Berchuck; Edwin S Iversen; Fergus J Couch; Prema Peethamabaran; Melissa C Larson; Kimberly R Kalli; Matthew L Kosel; Vijayalakshmi Shridhar; David N Rider; Mark Liebow; Julie M Cunningham; Joellen M Schildkraut; Thomas A Sellers; Ellen L Goode
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

3.  Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Authors:  Adam M Burgoyne; Polly J Phillips-Mason; Susan M Burden-Gulley; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; Susann M Brady-Kalnay
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

Review 4.  Receptor protein tyrosine phosphatase micro: measuring where to stick.

Authors:  A Radu Aricescu; Christian Siebold; E Yvonne Jones
Journal:  Biochem Soc Trans       Date:  2008-04       Impact factor: 5.407

5.  The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.

Authors:  Selvaraju Veeriah; Cameron Brennan; Shasha Meng; Bhuvanesh Singh; James A Fagin; David B Solit; Philip B Paty; Dan Rohle; Igor Vivanco; Juliann Chmielecki; William Pao; Marc Ladanyi; William L Gerald; Linda Liau; Timothy C Cloughesy; Paul S Mischel; Chris Sander; Barry Taylor; Nikolaus Schultz; John Major; Adriana Heguy; Fang Fang; Ingo K Mellinghoff; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

6.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

7.  Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z.

Authors:  Jeremy Pak Hong Chow; Akihiro Fujikawa; Hidetada Shimizu; Ryoko Suzuki; Masaharu Noda
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

8.  Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Authors:  Jianshi Yu; Scott Becka; Peng Zhang; Xiaodong Zhang; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

9.  PTPmu suppresses glioma cell migration and dispersal.

Authors:  Adam M Burgoyne; Juan M Palomo; Polly J Phillips-Mason; Susan M Burden-Gulley; Denice L Major; Anita Zaremba; Shenandoah Robinson; Andrew E Sloan; Michael A Vogelbaum; Robert H Miller; Susann M Brady-Kalnay
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  10 in total

1.  In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.

Authors:  Pei-Jun Liu; Chi-De Chen; Chih-Liang Wang; Yi-Cheng Wu; Chia-Wei Hsu; Chien-Wei Lee; Lien-Hung Huang; Jau-Song Yu; Yu-Sun Chang; Chih-Ching Wu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2015-01-31       Impact factor: 5.911

2.  Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion.

Authors:  Meghan T Logun; Kallie E Wynens; Gregory Simchick; Wujun Zhao; Leidong Mao; Qun Zhao; Subhas Mukherjee; Daniel J Brat; Lohitash Karumbaiah
Journal:  FASEB J       Date:  2019-08-09       Impact factor: 5.191

3.  Should I stay or should I go? Shedding of RPTPs in cancer cells switches signals from stabilizing cell-cell adhesion to driving cell migration.

Authors:  Polly J Phillips-Mason; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

Review 4.  Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules.

Authors:  Samantha L Hodges; Alexandra A Bouza; Lori L Isom
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

5.  A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Authors:  Polly J Phillips-Mason; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

6.  Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.

Authors:  Susan M Burden-Gulley; Mohammed Q Qutaish; Kristin E Sullivant; Mingqian Tan; Sonya E L Craig; James P Basilion; Zheng-Rong Lu; David L Wilson; Susann M Brady-Kalnay
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

7.  PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.

Authors:  Gil Covarrubias; Mette L Johansen; Jason Vincent; Bernadette O Erokwu; Sonya E L Craig; Abdelrahman Rahmy; Anthony Cha; Morgan Lorkowski; Christina MacAskill; Bryan Scott; Madhusudhana Gargesha; Debashish Roy; Chris A Flask; Efstathios Karathanasis; Susann M Brady-Kalnay
Journal:  Nanomedicine       Date:  2020-05-13       Impact factor: 5.307

Review 8.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 9.  Receptor protein tyrosine phosphatases and cancer: new insights from structural biology.

Authors:  Roman M Nikolaienko; Boadi Agyekum; Samuel Bouyain
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 10.  LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain.

Authors:  Francisca Cornejo; Bastián I Cortés; Greg M Findlay; Gonzalo I Cancino
Journal:  Front Cell Dev Biol       Date:  2021-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.